Equasens

Q3 2023 revenue - Seite 2

The MEDICAL SOLUTIONS Division had revenue of €1.8m, down 24% on Q3 2022. For the full first nine months, total revenue remained stable year-on-year, at €6.7m.

• This decline in revenue reflects the end of Medistory 4 license sales in H1 linked to the Ségur rollout initiated in Q3 2022.
• Today, the Division is offering a new subscription-based version of its Médistory software representing a source of recurring revenue.
• This Division accounted for 4 % of Equasens Group's total revenue.

• The FINTECH Division reported sales of €0.4m for Q3 2022 and €1.5m for the first 9 months, unchanged in relation to the same periods in 2022.
  • The continuing rise in refinancing rates continues to penalise the financing brokerage activity.
  • This Division accounted for 1 % of Equasens Group's total revenue.
    
    

2023 outlook

• Excluding the comparison base effect from the end of the Ségur deployment in 2022 and its exceptional contribution to revenue, growth momentum of the PHARMAGEST Division's remains solid.
• The AXIGATE LINK and e-CONNECT Divisions are also confident that their growth levels will remain strong for the remainder of the year.
• The MEDICAL SOLUTIONS Division is currently restructuring its offering and organization in order to enhance its performance.
• Based on the positive results of a major business development campaign, the FINTECH Division is confident about its outlook for year-end.
• The Group will continue to be on the lookout for external growth opportunities in France and Europe.
  
  

Financial calendar:

• Q4 2023 revenue: 6 February 2024 

About Equasens Group:

With more than 1,200 employees fulfilling a vital role as “Citizens in the Service of Health and Well-Being”, Equasens Group is today a key player in the European healthcare sector, providing software solutions to all healthcare professionals (pharmacists, primary care practitioners, hospitals, Hospital-at-Home structures, retirement homes, health centres) in both primary and secondary care sectors.

With operations in in France, Germany, Great Britain, Belgium, Ireland, Italy, and Luxembourg, Equasens Group today brings together healthcare professionals within a unique ecosystem in France and Europe benefiting people by making available the very best of technology.

Listed on Euronext Paris - Compartment A

Indexes: MSCI GLOBAL SMALL CAP - GAÏA Index 2020 - CAC SMALL and CAC All-Tradable